Vital Therapies reported $-20116000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Dynavax Technologies DVAX:US USD 61.4M 66.83M
Enanta Pharmaceuticals ENTA:US USD -27048000 5.49M
Insmed INSM:US USD -127697000 39.38M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Omeros OMER:US USD -50766000 13.33M
Orasure Technologies OSUR:US USD 875K 22.16M
Regulus Therapeutics RGLS:US USD -7563000 388K
Revance Therapeutics RVNC:US USD -77484000 19.64M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
United Therapeutics UTHR:US USD 314.3M 112.5M
Vital Therapies VTL:US USD -20116000 494K
Xoma XOMA:US USD -4372000 395K